Understanding allergies in healthy and allergic individuals
Official title: Understanding Allergies
Run by Stanford University · NCT04828603 · Data updated 2026-11-12
This study looks at how allergies work in both healthy people and those with allergies to see if it can help improve how allergies are diagnosed and treated.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Week to 90 Years |
| Sex | All |
| Enrollment | 2500 (estimated) |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Palo Alto, California) |
| Status | Recruiting |
| Started | October 2007 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | March 17, 2026 |
| Trial ID | NCT04828603 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study include any individuals who may have allergies.
✕Probably not a fit
Patients with special risks associated with venipuncture will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to enhance the accuracy of allergy diagnoses by investigating the cellular, humoral, genetic components, and physiological changes associated with allergic diseases. It will involve individuals who may have allergies, allowing researchers to gather comprehensive data on various allergic responses. The study will focus on understanding the underlying mechanisms of allergies to improve diagnostic methods and treatment approaches.
Why it matters
Potential benefit: If successful, this study could lead to more accurate diagnoses and better management of allergies for patients.
How similar studies have gone: Other studies have shown success in understanding allergies through similar observational approaches, indicating potential for valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Any individual with possible allergy Exclusion Criteria: * Patients with special risks attendant to venipuncture will be excluded
Where it's running
-
Sean N. Parker Center for Allergy and Asthma Research, Stanford University
Palo Alto, California, United States Recruiting
Study contacts
- Principal investigator: R. Sharon Chinthrajah, MD — Stanford University
- Study coordinator: SNP Center Inquiry
- Email: snpcenterallergy_inquiry@stanford.edu
- Phone: (650) 521-7237
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
What the Mayo Clinic is learning from blood clot tests in allergic reactions
This study tests whether real-time blood clotting markers can help understand and predict the severity of allergic reactions and anaphylaxis in patients 12 and older.
-
Does having allergic parents raise the chance of bronchiolitis in babies by 12 months?
We’re testing if infants with at least one allergic parent are more likely to have bronchiolitis by 12 months compared to infants whose parents have no allergies.
-
Using alpha-gal KO pork to see if it reduces reactions in people with Alpha-gal Syndrome
This study tests whether eating pork that lacks the alpha-gal allergen lowers reaction risk for people with Alpha-gal Syndrome, using a crossover design where each participant tries both KO and wild-type pork on separate days.
-
Lymph node examination during cat allergy immunotherapy
This project will test how lymph nodes react after a small cat allergen skin challenge in people with cat allergy who are either on long-term allergy shots or have never had immunotherapy.
-
How classroom indoor air affects children's allergies and wellbeing
This project will test whether continuous classroom and home air pollutant monitoring can identify pollution patterns linked to worse allergy or asthma symptoms in school-age children.
-
Beltaven shots for allergy to honeybee, paper wasp, or yellow jacket
This project will try subcutaneous Beltaven allergy shots in people aged 14 and up who have had systemic reactions to Apis mellifera, Polistes dominula, or Vespula stings to see if they are safe and helpful in routine care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.